keyword
MENU ▼
Read by QxMD icon Read
search

Prescriber's role in new anticoagulation

keyword
https://www.readbyqxmd.com/read/27909516/the-role-of-noacs-in-atrial-fibrillation-management-a-qualitative-study
#1
Katherine Kirley Md Ms, Goutham Rao Md, Victoria Bauer Bs, Christopher Masi Md PhD
Patients with atrial fibrillation (AF) benefit from anticoagulation to reduce stroke risk. However, 30-60% of patients with AF are not anticoagulated. This study explored physicians' reasons for under-treatment of AF, focusing on the role of the novel oral anticoagulants (NOACs). We interviewed primary care physicians and cardiologists involved in AF management in a variety of practice settings. We conducted interviews using a semi-structured format and analyzed the data using the Framework Method. Four themes emerged...
June 2016: Journal of Atrial Fibrillation
https://www.readbyqxmd.com/read/27464570/new-chronic-disease-medication-prescribing-by-nurse-practitioners-physician-assistants-and-primary-care-physicians-a-cohort-study
#2
Zachary A Marcum, Johanna E Bellon, Jie Li, Walid F Gellad, Julie M Donohue
BACKGROUND: Medications to treat and prevent chronic disease have substantially reduced morbidity and mortality; however, their diffusion has been uneven. Little is known about prescribing of chronic disease medications by nurse practitioners (NPs) and physician assistants (PAs), despite their increasingly important role as primary care providers. Thus, we sought to conduct an exploratory analysis to examine prescribing of new chronic disease medications by NPs and PAs compared to primary care physicians (PCPs)...
2016: BMC Health Services Research
https://www.readbyqxmd.com/read/27342144/role-of-protein-s-in-castration-resistant-prostate-cancer-like-cells
#3
Peng Ning, Jia-Guo Zhong, Fan Jiang, Yi Zhang, Jie Zhao, Feng Tian, Wei Li
Understanding how castration-resistant prostate cancer (CRPC) cells survive the androgen-deprivation condition is crucial for treatment of this advanced prostate cancer (PCa). Here, we reported for the first time the up-regulation of protein S (PROS), an anticoagulant plasma glycoprotein with multiple biological functions, in androgen-insensitive PCa cells and in experimentally induced castration-resistant PCa cells. Overexpression of exogenous PROS in LNCaP cells reduced androgen deprivation-induced apoptosis and enhanced anchorage-dependent clonogenic ability under androgen deprivation condition...
August 2016: Endocrine-related Cancer
https://www.readbyqxmd.com/read/26833971/direct-oral-anticoagulants-new-drugs-with-practical-problems-how-can-nurses-help-prevent-patient-harm
#4
Michael A Barras, David Hughes, Melanie Ullner
The safe use of anticoagulants requires a delicate balance between the risk of bleeding and the risk of thrombosis, particularly in drug-sensitive patients, such as older people. Recently-marketed "direct oral anticoagulants" are now being increasingly prescribed and administered in the hospital setting. Direct oral anticoagulants have pharmacological properties that are often unpredictable, and inter-patient variability in drug response is high. Therefore, people often require meticulous review and planning to ensure they receive optimal dosing and monitoring...
September 2016: Nursing & Health Sciences
https://www.readbyqxmd.com/read/26447877/venous-thrombosis-in-patients-with-high-grade-glioma
#5
REVIEW
Sophie Taillibert, Luc Taillandier, Emilie Le Rhun
PURPOSE OF REVIEW: High-grade glioma (HGG) patients are at particularly high risk of venous thromboembolism (VTE) occurrence and recurrence. VTE is associated with worsened survival in these patients. At present, the main challenge when prescribing anticoagulants in HGG patients is to address the risk of intracranial hemorrhage and provide the optimal treatment. RECENT FINDINGS: Here, we discuss the latest biological findings and their potential implications for better classification in daily practice and stratification of patients in future trials according to their risk of developing a VTE...
November 2015: Current Opinion in Oncology
https://www.readbyqxmd.com/read/26424298/clinical-features-of-ischemic-stroke-during-treatment-with-dabigatran-an-association-between-decreased-severity-and-a-favorable-prognosis
#6
Takeshi Hayashi, Yuji Kato, Takuya Fukuoka, Ichiro Deguchi, Hajime Maruyama, Yohsuke Horiuchi, Hiroyasu Sano, Yuito Nagamine, Satoko Mizuno, Norio Tanahashi
OBJECTIVE: Anticoagulation therapy with warfarin is associated with a favorable prognosis in ischemic stroke. Dabigatran, a new oral anticoagulant, is widely used to prevent ischemic stroke in non-valvular atrial fibrillation (NVAF) patients. However, its association with decreased severity and a favorable prognosis once ischemic stroke has occurred remains unknown. METHODS: We retrospectively reviewed all the patients with NVAF-associated ischemic stroke admitted to our hospital from April 2011 to December 2014 and included those who received dabigatran therapy...
2015: Internal Medicine
https://www.readbyqxmd.com/read/26369819/development-of-trypsin-like-serine-protease-inhibitors-as-therapeutic-agents-opportunities-challenges-and-their-unique-structure-based-rationales
#7
Guyan Liang, J Phillip Bowen
There has been a revolution in the development of effective, small-molecule anticoagulants and antiplatelet agents. Numerous trypsin-like serine proteases have been under active pursuit as therapeutic targets. Important examples include thrombin, factor VIIa, factor Xa, and β-tryptase with indications ranging from thrombosis and inflammation to asthma and chronic obstructive pulmonary disease (COPD). Trypsin-like serine proteases exhibit a highly similar tertiary folding pattern, especially for the region near the substrate binding pocket that includes the conserved catalytic triad consisting of histidine 57, aspartic acid 102, and serine 195...
2016: Current Topics in Medicinal Chemistry
https://www.readbyqxmd.com/read/26303220/a-pilot-study-on-the-impact-of-known-drug-drug-interactions-in-cancer-patients
#8
Silvia Ussai, Riccardo Petelin, Antonio Giordano, Mario Malinconico, Donatella Cirillo, Francesca Pentimalli
BACKGROUND: When a patient concomitantly uses two or more drugs, a drug-drug interaction (DDI) can possibly occur, potentially leading to an increased or decreased clinical effect of a given treatment. Cancer patients are at high risk of such interactions because they commonly receive multiple medications. Moreover, most cancer patients are elderly and require additional medications for comorbidities. Aim of this preliminary observational study was to evaluate the incidence of well known and established DDIs in a cohort of cancer outpatients undergoing multiple treatments...
2015: Journal of Experimental & Clinical Cancer Research: CR
https://www.readbyqxmd.com/read/25897256/personalized-antiplatelet-and-anticoagulation-therapy-applications-and-significance-of-pharmacogenomics
#9
REVIEW
Amber L Beitelshees, Deepak Voora, Joshua P Lewis
In recent years, substantial effort has been made to better understand the influence of genetic factors on the efficacy and safety of numerous medications. These investigations suggest that the use of pharmacogenetic data to inform physician decision-making has great potential to enhance patient care by reducing on-treatment clinical events, adverse drug reactions, and health care-related costs. In fact, integration of such information into the clinical setting may be particularly applicable for antiplatelet and anticoagulation therapeutics, given the increasing body of evidence implicating genetic variation in variable drug response...
2015: Pharmacogenomics and Personalized Medicine
https://www.readbyqxmd.com/read/25616425/relevance-of-p-glycoprotein-in-stroke-prevention-with-dabigatran-rivaroxaban-and-apixaban
#10
REVIEW
C Stöllberger, J Finsterer
BACKGROUND: The new oral anticoagulants (NOAC) dabigatran etexilate, rivaroxaban, and apixaban show similar efficacy for stroke prevention in patients with atrial fibrillation (AF) as the vitamin K antagonist warfarin. Absorption of NOACs is dependent on the intestinal P-glycoprotein (P-gp) system and P-gp activity is modulated by a variety of drugs and food components. OBJECTIVE: The aim of this review is to give an overview of P-gp-associated drug-drug and drug-food interactions with NOACs in AF patients...
April 2015: Herz
https://www.readbyqxmd.com/read/25179482/new-oral-anticoagulants-for-the-prevention-of-thromboembolic-complications-in-atrial-fibrillation-a-single-centre-experience
#11
Iwona Gorczyca-Michta, Beata Wożakowska-Kapłon
BACKGROUND: Prevention of thromboembolic complications is a priority in patients with atrial fibrillation (AF). Based on the current guidelines, the role of vitamin K antagonists (VKA) in stroke prevention has decreased in favour of novel oral anticoagulants (NOAC). AIM: To evaluate the proportion of AF patients who were prescribed a NOAC, compare populations of patients treated with VKA and NOAC, and identify factors predisposing to NOAC prescription at hospital discharge of AF patients...
2015: Kardiologia Polska
https://www.readbyqxmd.com/read/25088126/novel-anticoagulants-vs-warfarin-for-stroke-prevention-in-atrial-fibrillation
#12
REVIEW
Mohit K Turagam, Poonam Velagapudi, Navneeth R Bongu, Abraham G Kocheril
Warfarin has remained the mainstay of stroke prevention in atrial fibrillation for the past 60 years. Recently, two new groups of novel oral anticoagulants- direct thrombin inhibitors (dabigatran) and factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) have shown promising results in well conducted clinical trials in terms of efficacy, safety and convenience of usage. However, in real world practice these novel agents come with their share of side effects and drawbacks which the prescribing physician must be aware about...
2014: Cardiovascular & Hematological Disorders Drug Targets
https://www.readbyqxmd.com/read/24919870/pharmacogenetics-role-in-the-safety-of-acenocoumarol-therapy
#13
E Jiménez-Varo, M Cañadas-Garre, C I Henriques, A M Pinheiro, M J Gutiérrez-Pimentel, M Á Calleja-Hernández
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and prevention of thrombotic disorders in many countries, despite the recent approval of the new oral anticoagulants (NOACs). Although effectiveness and safety of VKAs are tightly associated to maintaining the patient within the international normalised ratio (INR) therapeutic range (TWR), they have been likened to NOACs when patients are in good INR control (≥66% of TWR). Therefore, assessing the safety of patients should be a priority in the selection of the anticoagulation therapy...
September 2, 2014: Thrombosis and Haemostasis
https://www.readbyqxmd.com/read/24814537/pharmacology-benefits-unaddressed-questions-and-pragmatic-issues-of-the-newer-oral-anticoagulants-for-stroke-prophylaxis-in-non-valvular-atrial-fibrillation-and-proposal-of-a-management-algorithm
#14
REVIEW
Salvatore Rosanio, Abdul M Keylani, Darrin C D'Agostino, Craig M DeLaughter, Antonio Vitarelli
This systematic review aims to provide an update on pharmacology, efficacy and safety of the newer oral direct thrombin and factor Xa inhibitors, which have emerged for the first time in ~60 years as cogent alternatives to warfarin for stroke prophylaxis in non-valvular atrial fibrillation. We also discuss on four of the most common clinical scenarios with several unsolved questions and areas of uncertainty that may play a role in physicians' reluctance to prescribe the newer oral anticoagulants such as 1) patients with renal failure; 2) the elderly; 3) patients presenting with atrial fibrillation and acute coronary syndromes and/or undergoing coronary stenting; and 4) patients planning to receive AF ablation with the use of pulmonary vein isolation...
July 1, 2014: International Journal of Cardiology
https://www.readbyqxmd.com/read/23919835/pharmacogenetic-guided-dosing-of-coumarin-anticoagulants-algorithms-for-warfarin-acenocoumarol-and-phenprocoumon
#15
REVIEW
Talitha I Verhoef, William K Redekop, Ann K Daly, Rianne M F van Schie, Anthonius de Boer, Anke-Hilse Maitland-van der Zee
Coumarin derivatives, such as warfarin, acenocoumarol and phenprocoumon are frequently prescribed oral anticoagulants to treat and prevent thromboembolism. Because there is a large inter-individual and intra-individual variability in dose-response and a small therapeutic window, treatment with coumarin derivatives is challenging. Certain polymorphisms in CYP2C9 and VKORC1 are associated with lower dose requirements and a higher risk of bleeding. In this review we describe the use of different coumarin derivatives, pharmacokinetic characteristics of these drugs and differences amongst the coumarins...
April 2014: British Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/23722223/mood-altering-drugs-in-the-trauma-population-hidden-dangers-deadly-combinations
#16
Diane T Kupensky, Barbara M Hileman, Elisha A Chance, Susan L Jones
Depression is on the rise, and as a result, there is an increased use of psychotropic medications. Also, nonreversible anticoagulants have entered the market and are increasing in use. In combination, these developments have created new risk factors for trauma patients. Our study examined the occurrence of trauma patients who present with a history of psychotropic medication, and we also sought to determine the rate of psychotropic medication and blood thinner use in the older adults. Because these drugs may play a role in causing injury and worsening outcomes, prescribers need to be aware of the patients' medication history and the potential risks...
April 2013: Journal of Trauma Nursing: the Official Journal of the Society of Trauma Nurses
https://www.readbyqxmd.com/read/23663291/role-of-p-glycoprotein-in-the-uptake-efflux-transport-of-oral-vitamin-k-antagonists-and-rivaroxaban-through-the-caco-2-cell-model
#17
Liliane Gschwind, Victoria Rollason, Youssef Daali, Pascal Bonnabry, Pierre Dayer, Jules Alexandre Desmeules
Vitamin K antagonists (VKAs) are prescribed worldwide and remain the oral anticoagulant of choice. These drugs are characterized by a narrow therapeutic index and a large inter- and intra-individual variability. P-glycoprotein could contribute to this variability. The aim of this study was to investigate the involvement of P-gp in the transport of acenocoumarol, phenprocoumon and warfarin using an in vitro Caco-2 cell monolayer model. These results were compared with those obtained with rivaroxaban, a new oral anticoagulant known to be a P-gp substrate...
October 2013: Basic & Clinical Pharmacology & Toxicology
https://www.readbyqxmd.com/read/23647929/-atrial-fibrillation-from-detection-to-treatment-role-of-the-family-physician-cardiologist-and-other-specialists-new-models-of-clinical-management
#18
Santiago Díaz Sánchez, José M Lobos Bejarano, José Ramón Gonzalez-Juanatey
The prevalence of atrial fibrillation (AF) in adults in Spain is estimated to be 4.4% of the population aged 40 years or more, corresponding to a mean of 30 to 40 patients per family physician. The importance of this common arrhythmia lies, above all, in its close association with stroke and other systemic embolisms, among other possible complications. Diagnosis of AF is based on electrocardiographic recording and can consequently be made by the family physician, who should make an overall assessment of the patient's health, including risk factors, comorbidity and type of AF and evaluate embolic and hemorrhagic risk...
April 2013: Atencion Primaria
https://www.readbyqxmd.com/read/23634925/the-role-of-anticoagulants-antiplatelet-agents-and-their-reversal-strategies-in-the-management-of-intracerebral-hemorrhage
#19
REVIEW
Robert F James, Viktoras Palys, Jason R Lomboy, J Richard Lamm, Scott D Simon
New anticoagulant and antiplatelet medications have been approved and are prescribed with increased frequency. Intracranial hemorrhage is associated with the use of these medications. Therefore, neurosurgeons need to be aware of these new medications, how they are different from their predecessors, and the strategies for the urgent reversal of their effects. Utilization of intraluminal stents by endovascular neurosurgeons has resulted in the need to have a thorough understanding of antiplatelet agents. Increased use of dabigatran, rivaroxaban, and apixaban as oral anticoagulants for the treatment of atrial fibrillation and acute deep venous thrombosis has increased despite the lack of known antidotes to these medications...
May 2013: Neurosurgical Focus
https://www.readbyqxmd.com/read/23498071/-the-role-of-internal-medicine-in-preventing-stroke-in-atrial-fibrillation
#20
REVIEW
Miguel Hernández, Carmen Suárez
Atrial fibrillation (AF) is the most frequent supraventricular arrhythmia in our environment. The incidence and prevalence of this disease increase with age and with the presence of concomitant cardiovascular disorders; consequently, AF is frequently encountered in the field of internal medicine. Elderly patients have a series of characteristics that lead to a high risk of thromboembolic complications and hemorrhagic events. Internal medicine specialists should be trained in the global management of this disease, in order to correctly evaluate the risk of complications and take unusually difficult decisions...
October 2012: Medicina Clínica
keyword
keyword
78972
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"